发明名称 Preparation and use of 2-methyl-5-phenylisoxazolidine
摘要 (a) An alkali metal base (hydroxide, oxide, carbonate, bicarbonate or sesquicarbonate), an acid addition salt of N-methylhydroxylamine, and (iii) water are mixed together to form a reaction mixture in which the acid of the acid addition salt has been neutralized. (b) Reaction mixture from (a) and formaldehyde or formalin are mixed together and the resultant mixture is subjected to reaction conditions that produce a reaction mixture in which N-methylnitrone has been formed. (c) Reaction mixture from (b) and styrene are mixed and the resultant mixture to subjected to reaction conditions that produce a reaction mixture in which 2-methyl-5-phenylisoxazolidine has been formed. Preferably, 2-methyl-5-phenylisoxazolidine formed in (c) is hydrogenated such that N-methyl-3-phenyl-3-hydroxypropylamine is formed, which in turn is reacted with 4-halobenzotrifluoride such that N-methyl-3-phenyl-3-[4-trifluoromethyl)phenoxy]propylamine is formed. Conversion of the N-methyl-3-phenyl-3-[4-trifluoromethyl)phenoxy]propylamine to its racemic hydrochloride salt provides fluoxetine hydrochloride, a widely used antidepressant.
申请公布号 US5760243(A) 申请公布日期 1998.06.02
申请号 US19970901235 申请日期 1997.07.25
申请人 ALBEMARLE CORPORATION 发明人 THERIOT, KEVIN J.
分类号 C07D261/02;C07D261/04;(IPC1-7):C07D261/02 主分类号 C07D261/02
代理机构 代理人
主权项
地址